Combretastatin A4 Nanodrug-Induced MMP9 Amplification Boosts Tumor-Selective Release of Doxorubicin Prodrug

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 31(2019), 44 vom: 02. Nov., Seite e1904278
Auteur principal: Jiang, Jian (Auteur)
Autres auteurs: Shen, Na, Ci, Tianyuan, Tang, Zhaohui, Gu, Zhen, Li, Gao, Chen, Xuesi
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article combination delivery doxorubicin prodrug drug delivery matrix metalloproteinases nanomedicine Antibiotics, Antineoplastic Delayed-Action Preparations Prodrugs Stilbenes plus... methoxy poly(ethylene glycol)-b-poly(L-glutamic acid-co-L-phenylalanine) Glutamic Acid 3KX376GY7L Polyethylene Glycols 3WJQ0SDW1A Phenylalanine 47E5O17Y3R Doxorubicin 80168379AG Matrix Metalloproteinase 9 EC 3.4.24.35 fosbretabulin I5590ES2QZ